Tuesdays with Wilcockson: The A-Z of 2012, Part I

The 2012 season has seen cycling attain some remarkable landmarks, including the first Canadian racer to win the Giro d’Italia, the first Brit to win the Tour de France, and the biggest-ever crowds to watch an Olympic road race. The year has also seen the sport dragged through its most damaging doping scandal in the ongoing USADA case against Lance Armstrong and his longtime team manager and business partner Johan Bruyneel. But with pro cycling now emerging as one of the cleanest sports in the world, there are many more feel-good stories to report than bad-news yarns. I’ve divided my A to Z review of a momentous season into two parts, starting this week from Armstrong to Magni.

A is for Armstrong. That’s the one whose first name is Kristin. The 39-year-old American came back from starting a family to brilliantly defend her Olympic women’s time trial gold medal at the London Games, defeating reigning world champion Judith Arndt by 15 seconds in the 29-kilometer event.

B for Boonen. Belgium’s perennial road star, Tom Boonen, returned to his very best form to ace four of the cobbled spring classics: Paris-Roubaix, Tour of Flanders, Ghent-Wevelgem and E3 Prijs Vlaanderen. Later in the year he won the Belgian national road championship, took the first edition of the two-day World Ports Classic, won the semi-classic Paris-Brussels, and helped his Omega Pharma-Quick Step team win gold in the inaugural world team time trial championship for pro squads.

C for Contador. Spanish fans (and his Saxo Bank team boss Bjarne Riis) were ecstatic when Alberto Contador returned from his much-delayed Clenbuterol-positive suspension to win the Vuelta a España for a second time. Whatever others think about his doping ban, the 29-year-old Spaniard earned the Vuelta win with an audacious solo move far from the finish of stage 17 between Santander and Fuente Dé, to dispossess national rival Joaquin Rodriguez from the leader’s red jersey.

D for Dombrowski. Only two years ago, Joe Dombrowski was a skinny teenager from Virginia who was given the chance to try out with the U.S. development team, Trek-Livestrong, by its director Axel Merckx. Today, he’s about to enter the UCI WorldTour with Team Sky after an amazing under-23 season with Bontrager-Livestrong that saw Dombrowski use his climbing skills to win two mountain stages and the overall title of Italy’s GiroBio; and take top-10 finishes at the Tour of the Gila, Tour of Utah and USA Pro Challenge. Tomorrow: the world.

E for Erythropoietin. Just when we thought we’d maybe heard the last of EPO in cycling, this blood-boosting drug again hit the headlines in 2012. And not just from former U.S. Postal Service team riders in their testimonies given in the USADA investigation (see “U for USADA”). Among those foolish enough to use and test positive for EPO were a wide range of athletes, including Tour of Turkey “winner” Ivailo Gabrovski of Bulgaria; French domestique Steve Houanard of the AG2R team; South African veteran David George, a U.S. Postal team rider 12 years ago; and two Gran Fondo New York prize winners, American David Anthony and Italian Gabriele Guarini.

F for Froome. If you’d told Chris Froome 15 months ago that by the end of 2012 he’d finish second at the Tour de France (and win a mountain stage), place second and fourth at the Vuelta a España, come fourth at the Dauphiné, and win a bronze medal in the London Olympics time trial, he’d have said, “You must be joking.” But that’s what this Team Sky rider has just accomplished. Not bad for a bookish 27-year-old born in Kenya and raised in South Africa who now races for Great Britain.

G for Gerrans. The Australian owners of the brand-new Orica-GreenEdge team could barely believe their luck when Simon Gerrans began their tenure by winning the year’s first two races: the Aussie national title and the Tour Down Under. And it only got better, with Gerrans taking his first monument, Milan-San Remo, in March; placing second at the Clasica San Sebastian in August; and winning the GP de Québec in September.

H for Hesjedal. Ever since he was winning top mountain bike races in his early-20s (he narrowly lost the 2003 world cross-country championship to Filip Meirhaeghe, who would later test positive for EPO), Ryder Hesjedal knew he had exceptional talent for cycling. After years of riding tirelessly for other team leaders, he blossomed at Team Slipstream with sixth overall at the 2010 Tour de France, and this year showed all his exceptional ability, climbing talent and grit to become the first Canadian to win the Giro d’Italia. He did it with great consistency: Garmin won the early team time trial at Verona; Hesjedal was heroic on the summit finishes at Rocca di Cambio, Cervinia, Cortina, Alpe di Pampeago and the Passo di Stelvio, and he crowned his victory over Joaquim Rodriguez in the final-stage time trial though the streets of Milan.

I for Iglinskiy. For most of his nine years as a pro racer, Maxim Iglinskiy has worked as a domestique for team leader and fellow Kazakh, Alexander Vinokourov, while still winning the occasional race. This spring, he emerged from the Astana veteran’s shadows by placing second to Fabian Cancellara at Italy’s Strade Bianche classic (a race he won in 2010), and then grinding out a late victory over Vincenzo Nibali at the last of the spring classics, Liège-Bastogne-Liège.

J for Jensy. Every bike-racing fan loves the aggressive riding of German veteran Jens “Jensy” Voigt, 40, who out-did himself in 2012 with nine months of solid racing from January to September for RadioShack-Nissan. The highlights included top-three stage finishes at Paris-Nice, the Tour of California and Tour de France—and then a magnificent stage victory on the Aspen-Beaver Creek stage of Colorado’s USA Pro Challenge, riding alone for 150 kilometers in rain and wind over Independence Pass and Battle Mountain.

K for Kulhavy. He wasn’t the favorite to win gold in the men’s cross-country at the London Olympics, but Czech mountain biker Jaroslav Kulhavy, 27, took one of the most exciting wins off-road racing has seen in a sprint finish with Swiss rival Nino Schurter. Kulhavy, the 2011 world champion, hadn’t won a major race all year before the Olympics. He went on to win the biggest French mountain-bike race, the marathon Roc d’Azur, ahead of Specialized teammate Christoph Sauser—and there’s talk that Kulhavy may convert to road racing in future seasons.

L for Lance. Some 18 months after his final bike race, Lance Armstrong was no longer a seven-time Tour de France winner, but merely a former world and U.S. road champion, the first American to win European classics (Flèche Wallonne and Clasica San Sebastian), along with a host of North American victories, after USADA (see “U is for USADA”) stripped him of all his post-cancer results because of doping.

M for Magni. Italian legend Fiorenzo Magni died in October at age 91. Known as the Lion of Flanders for his three consecutive victories at the Tour of Flanders (1949, ’50 and ’51), he also won three editions of the Giro d’Italia (1948, ’51 and ’55) and three Italian road titles. They were amazing accomplishments in an era when Gino Bartali and Fausto Coppi were also at their zenith. An accomplished businessman until his death, Magni is also remembered for bringing the first non-cycling sponsor to the sport: Nivea began as his team’s title sponsor in 1954.

 

You can follow John at twitter.com/johnwilcockson

Boonen image: Photoreporter Sirotti
Contador image: John Pierce, Photosport International

Friday Group Ride #129

Is it just me? It felt like the Tour (grand as it always is) was somehow lessened by these Olympics. Riders who might have gone harder in France saved themselves for London. Tom Boonen comes to mind immediately. Even Mark Cavendish, who was always going to take a back seat with Team Sky teammate Bradley Wiggins in yellow, used the Tour as training for the road race in his home country, rather than going full gas for another green jersey. A further cadre of riders pulled out of the Tour consoling themselves that the Olympics might still define their season, Thor Hushovd (he missed both races in the end) among them.

So what do we think of that? Has the Olympics, the road race and time trial, been worth it? Did you care when Alexandre Vinokourov rode off with the gold medal? Was Wiggins’ ride in the TT a valedictory, a simple victory lap or a true coronation? Did the Olympics turn you on?

I will say that I was tremendously disappointed in the road race. Team GB didn’t execute the plan for Cavendish. In fact, having watched Wiggins and Chris Froome both medal in the time trial, you have to ask if they were even the right guys to have in the road race. Were they saving themselves for their own event at Cav’s expense?

And then watching Vinokourov, one of the enduring faces of the sport’s doping past, cross the line, arms aloft, turned my stomach. Here is a guy who hasn’t won a race all year, but suddenly he has the legs to take a gold medal. When Rigoberto Uran turned to look over his right shoulder I immediately thought, “NO!NO!NO!” And it was over.

On the flip side of the coin, Marianne Vos’ road race win over Lizzie Armitstead was nail-bitingly dramatic, and certainly helped the pro women get some much deserved camera time. Kristin Armstrong’s gold in the TT a few days later was also good. Watching her with her son, on the podium, made me all emotional. And I abhor time trials.

So this week’s Group Ride asks: Was it worth it? Was Olympic cycling (and yes, I know the track events are still in progress) a worthy distraction from our normal program? Did London 2012 lessen the Tour, or was it another marquis event that will bring lasting attention to the sport? My British friends are thinking the latter, but how does this all look from your corner of the globe?

Photo: © Surrey County Council

The Legacy

Some things in this world are unlikely. Finding Bigfoot is pretty unlikely. So is peace in the Middle East. Other things are just impossible. Finding Bigfoot eating dinner at a diner with Elvis, safe to say, is impossible.

Somewhere in the middle of these two poles lies the possibility that the suit Greg LeMond has filed against Trek Bicycles and their countersuit against him will be settled out of court. LeMond, for better or worse, seems to want his day in court.

In broad strokes, the cases are pretty simple. LeMond is suing Trek for failing to “exert best efforts regarding the LeMond brand.” In realpeople speak that’s, ‘They didn’t sell enough of my bikes.’ Following LeMond’s suit, Trek countersued and terminated its licensing agreement in April of this year. Today, the Lemond Bicycles web site is a single page allowing purchasers to register their bikes for warranty.

The real issue here isn’t sales figures, it’s LeMond’s mouth. It’s roots are in a report that LeMond read in 2001 that revealed Lance Armstrong’s relationship with Michele Ferrari. To LeMond, who was very familiar with Ferrari’s past vis-à-vis doping, that relationship could only mean one thing: Lance was doping. There was a certain sort of logic to it. Say your best friend is John Gotti. And say you tell a newspaper that he has a great mind for business and he has helped you with some of your business dealings, a reasonable person could understandably come to the conclusion that you, my friend, are a mobster.

Does that give anyone the right to accuse you of being a mobster in public? Not unless he is a prosecutor preparing to bring charges under RICO against you. To be fair, LeMond hasn’t actually said, “Armstrong is on dope,” but if you take the body of statements LeMond has made, his belief is clear. Consider: “If Armstrong’s clean, it’s the greatest comeback. And if he’s not, then it’s the greatest fraud,” and “In the light of Lance’s relationship with Ferrari, I just don’t want to comment on this year’s Tour. This is not sour grapes. I’m disappointed in Lance, that’s all it is.”

Would you say that about an athlete you thought was clean?

So LeMond thinks Armstrong is a doper. Newsflash: he’s not alone. There are plenty of cycling fans, competitors and members of the media who think so as well. The difference is, with the exception of a guy named Walsh, they all have the good sense not to accuse someone of something if they lack proof.

This was LeMond’s downfall. Word on the street is that Armstrong placed Trek CEO John Burke in the unenviable position of needing to mediate between the only two American Tour de France winners. Burke asked LeMond to temper his statements and confine them to speaking generally about doping. LeMond was unable to.

The case before Judge Richard Kyle has gone far afield. LeMond is notoriously unpleasant to do business with (an inside source pegs him as the downfall of the Clark Kent brand and the near failure of the paint and restoration company CyclArt), in part because he is unafraid of litigation. One former business associate who asked to remain anonymous used a single word to describe him: “Nightmare.”

Were the case really about the bikes, Lance Armstrong’s ex-wife, Kristin Armstrong would not have been deposed, nor would he have showed up at an Armstrong press conference to question him about his planned anti-doping program. In short, LeMond is attempting to make the case about Armstrong rather than his dissatisfaction with Trek’s efforts to sell his brand.

In an interview with the New York Daily News, LeMond attempted to cast his concern about doping in general and EPO in specific as a concern for athletes. He cited the deaths of more than 100 cyclists who are believed to have been taking EPO. However, LeMond never brought up his concern before the controversy with Armstrong. Put another way, have you ever heard LeMond mention the name of Johannes Draaijer, a Dutch cyclist on EPO, who had a heart attack and died in his sleep?

Trek claims it has done right by LeMond and that the relationship was lucrative for both. Since 1995, Trek reports it has earned more than $100 million, delivering some $5 million to LeMond’s coffers. LeMond points to a meager $10,393 in sales (possibly fewer than five bikes) in France between 2001 and 2007. Given the success of Bernard Hinault’s line of bikes in the United States, one can ask if LeMond could reasonably expect to do more in France.

What’s that you say? Hinault isn’t a household name in America? True, but nearly anyone willing to spend more than $2000 on a bicycle (only one bike in the LeMond line retailed for less than $2000) knows the Hinault name. And while LeMond may have had a large fan base in France, it can’t compare to the legions that adore Hinault in his home country. Fair comparison.

The point? LeMond’s case seems rather weak. I’ve written on this once before, for Slowtwitch. And while I’d rather see LeMond leave Armstrong alone—and addressed an open letter to him on Road Bike Action’s site—that’s really what this case is about.

But, you ask, what does Armstrong’s alleged doping have to do with LeMond’s bike business? LeMond will tell you it has everything to do with it. If LeMond can demonstrate to the court that Armstrong has doped, then he can demonstrate that Armstrong had motivation to have LeMond silenced. But what could silence LeMond? How about the threat of the shelving of his brand?

In short, LeMond will turn this case into an accusation of extortion against John Burke and Lance Armstrong. His legal team has already deposed Armstrong’s ex-wife; don’t think for a second that he won’t at least try to depose Mr. Seven.

The real question isn’t what LeMond and his legal team will reveal about Armstrong and his alleged doping but rather what LeMond’s actual motivation is. While it is conceivable that LeMond and his team could find a person or persons to allege doping on Armstrong’s part, finding definitive proof that Armstrong doped is as likely as finding Buggs Bunny sharing a slice of pie with Elvis and Bigfoot at our aforementioned diner.

Given the difficulty of the challenge facing LeMond, one must wonder what his motivation truly is. It can’t be exposing the danger of EPO, otherwise he would have been speaking out against EPO use more forcefully earlier. LeMond didn’t have a lot to say during the Festina Affair in 1998, yet just three years later, he had a lot to say about the second American to win the Tour de France three times.

That’s the rub: LeMond’s legacy. While this is pure conjecture on my part, no other explanation makes sense of the energy and money LeMond has sunk into this case. While the psychic toll this case has taken on his family can’t be calculated—it was enough, though, that Kathy LeMond sat across from Kristin Armstrong during her deposition (one wonders who was more unnerved by Mrs. LeMond’s presence)—the cost in legal fees can, and is said to be at or above seven figures.

If LeMond can impeach Armstrong and demonstrate a strong likelihood that he doped during his seven Tour de France wins, LeMond could win two things. First, he could show that in silencing LeMond and dropping his line, John Burke wasn’t acting in the best interest of the LeMond line. Second, by tearing down America’s most successful cyclist, LeMond will regain his rank as the best American cyclist.

But what’s the chance he’ll succeed, and even if he does, in whose eyes will he have won?

Image: John Pierce, Photosport International